Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- Drug Diversion
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
$25.00
Prescription drug diversion is a serious problem and fuels the current US epidemic of drug misuse, abuse, and addiction. Healthcare practitioners need to be able to identify and prevent drug diversion in their practices, by patients or staff members. This course presents the different mechanisms used to divert drugs and strategies to detect and prevent diversion.
- Telemedicine
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC
$0.00
Telehealth has become an integral part of the healthcare system as it provides patients, healthcare providers, and staff with a flexible option to meet healthcare needs. The use of telehealth proliferated during the COVID-19 pandemic, with regulations and payment structures modified to allow payments to clinicians to provide new ways of care. This course covers telehealth best practices and use cases to transform care delivery by integrating workflows, administrative documentation, and achieving high patient satisfaction.
- 1.00 AMA PRA Category 1 Credit™
- 0.10 ANCC
$0.00
This module reviews the population health impact of vaccinations on the community. This includes the vaccine campaigns, health benefits, risk-factors, vaccine hesitancy and impact of misinformation so that health professionals can effectively communicate with patients about vaccinations. This module will be a lecture style format with integrated questions throughout. This module will be approximately 1 hour in length for viewing and completion of the evaluation. This module is approved for 1 hour of CME.
- Vaccinations
- 1.00 AMA PRA Category 1 Credit™
- 0.10 ANCC
$0.00
This module reviews the population health impact of vaccinations on the community. This includes the vaccine campaigns, health benefits, risk-factors, vaccine hesitancy and impact of misinformation so that health professionals can effectively communicate with patients about vaccinations. This module will be a lecture style format with integrated questions throughout. This module will be approximately 1 hour in length for viewing and completion of the evaluation. This module is approved for 1 hour of CME.
- Opioid Use Disorder (OUD)
- Pharmacology
- 10.00 AMA PRA Category 1 Credit™
- 10.00 ANCC
- 10.00 Association of Social Work Boards (ASWB)
$70.00
Morphine and heroin were first synthesized and used medicinally in the nineteenth century, and recreational and illicit use followed. Historically, heroin dependence has been difficult to treat successfully, with poor outcome being attributed to patient characteristics, environmental factors, and the powerful reinforcing effects of the drug. Agonist-replacement therapy was introduced more than 40 years ago and represented a breakthrough in the management of heroin addiction.
- Prescribing: Opioid(s)
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
$30.00
This on-demand course provides an overview for Iowa clinicians of the CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. It is jointly provided by Iowa Medical Society.Iowa Licensure Requirement: The course fulfills Iowa's requirement for clinicians who prescribe opioids (Nurse Practitioners, Physician Assistants/Associates, Physicians) to complete 2 hours of continuing education regarding the CDC Clinical Practice Guideline for Prescribing Opioids for Pain.
- Prescribing: Opioid(s)
- Pain Management: Opioid(s)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
$0.00
This module provides an overview of the 2022 Clinical Practice Guideline recommendations intended for clinicians providing pain care, including those prescribing opioids for outpatients with acute, subacute, and chronic pain. You will learn how to apply the recommendations as flexible standards of care to enable patient-centered decision-making, taking into account an individual’s well-being and what may be expected to happen based on their health or medical conditions.WB4701
- Drug Diversion
- Prescribing: Controlled Substance(s)
- 3.00 AMA PRA Category 1 Credit™
- 3.00 ANCC
$225.00
Prescribing controlled substances for pain and other conditions is a major focus of both the medical community and legislatures throughout the country. The consequences of the use and abuse of controlled substances are frequently in the news. La. R.S. 40:978.3 requires new prescribers of controlled substances to complete a one-time, three-hour continuing education program on best practices for prescribing, drug diversion prevention, and appropriate treatment for addiction prior to licensure from the Board of Pharmacy.
- Pharmacology
- Weight Management
- 15.00 AMA PRA Category 1 Credit™
- 15.00 ANCC
$105.00
Obesity is a chronic, progressive, relapsing, multifactorial disease resulting in metabolic and biomechanical morbidities and premature mortality, and its prevalence has risen to unacceptable levels in the United States and worldwide. Healthy diet, exercise, and behavioral interventions are crucial components of management but are largely unsuccessful in achieving and maintaining weight reduction sufficient to reduce morbidities and prevent premature mortality because the chronic neuroendocrine disease of obesity remains unaddressed.
- Opioid Use Disorder (OUD)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
$0.00
Patients and health care professionals (HCPs) face additional challenges when the treatments prescribed for pain management (e.g., opioids) lead to substance use problems. HCPs must then re-evaluate treatment plans for acute, subacute, and chronic pain and encourage treatment for opioid use disorder (OUD). There are strategies available to HCPs to help identify patients at risk for OUD, most notably found in the 2022 CDC Guideline for Prescribing Opioids, which could help prevent OUD in patients through screening and identifying alternate treatments.